Composition for eyes and having improved drying protection and retention
An ophthalmic composition and the technology of the composition are applied in the direction of medical preparations containing active ingredients, drug combinations, drug delivery, etc., which can solve problems such as lack of value and loss of lubricating eyes, and achieve the purpose of improving ocular surface health and encapsulating products. High efficiency and enhanced bioavailability
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Benefits of technology
Problems solved by technology
Method used
Image
Examples
preparation example Construction
[0049] In the preparation method of the ophthalmic composition of the present invention, the second solute provided is hyaluronic acid or a pharmaceutically acceptable salt thereof, and its concentration in the composition is 0.1-3.0 w / v%. Hyaluronic acid is a compound accepted by the ophthalmic community to protect biological tissues or cells from compressive forces. The viscoelastic properties of hyaluronic acid (i.e. hard elastic at rest but less viscous under small shear forces) allow hyaluronic acid to act essentially as a shock absorber for cells and tissues, hyaluronic acid also It has relatively large water absorption and storage capacity. If sodium hyaluronate is to be added, warm the solution to a temperature not lower than 70°C, then add sodium hyaluronate, and stir the warm solution for 20-30 minutes until the sodium hyaluronate is completely dissolved.
[0050] In the preparation method of the ophthalmic composition of the present invention, the provided second s...
Embodiment 1
[0062] Ophthalmic compositions with improved dryness protection and retention, comprising concentrations of: 0.5w / v% cyclosporin A, 1.0w / v% nanomicelle in situ gel, 0.5w / v% Hyaluronic acid, 0.05w / v% naphazoline, adding buffering agent sodium citrate to adjust the pH of the composition is 7.5, and adding an equal proportion of sodium ascorbate and sorbitol mixture, so that the composition weight osmolality is adjusted to 300mOsmol / kg.
[0063] A process for the preparation of an ophthalmic composition with improved dryness protection and retention comprising the steps of:
[0064] 1) Mix cyclosporine A, glycerin and polyethylene glycol 15-hydroxystearate at a weight ratio of 1:3.5:5, then stir in a water bath at 85°C until dissolved, and then add 2 times the amount Double-distilled water, under the condition of power 200W, pulse 5s / 10s, ultrasonically stirred for 40s, then cooled to room temperature, and adjusted the pH of the obtained micellar solution to 7, that is, nanomice...
Embodiment 2
[0069] The difference between this example and Example 1 is that: in step 1), redistilled water contains 0.05mM gulose and 0.08mM cyclohexanol; Hydrophobic groups of polyethylene glycol fatty acid esters are combined, while the hydrophilic groups of polyethylene glycol 15-hydroxystearate are exposed, and gulose and cyclohexanol are combined with hydrophilic groups during ultrasonic energy transfer , due to the addition of the two, the steric hindrance between the formed nanoparticles increases, which enhances the mutual repulsion of the nanoparticles with small particle size in the system, avoids the self-aggregation phenomenon caused by the smaller particle size, and enhances the combination Antioxidant protection and stability of the compound, on the other hand, the hydrophilic groups of the two can increase the hydrophilicity of the composition and help enhance its penetration of the eye membrane. When the composition is applied to the eye, it can Relieve the heat stress ef...
PUM
Property | Measurement | Unit |
---|---|---|
The average particle size | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com